financetom
Business
financetom
/
Business
/
Triplepoint Venture Growth BDC Insider Bought Shares Worth $348,978, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Triplepoint Venture Growth BDC Insider Bought Shares Worth $348,978, According to a Recent SEC Filing
Mar 10, 2026 10:23 PM

10:48 AM EST, 12/12/2025 (MT Newswires) -- Sajal Srivastava, Director, President and Chief Investment Officer, on December 10, 2025, executed a purchase for 51,790 shares in Triplepoint Venture Growth BDC ( TPVG ) for $348,978. Following the Form 4 filing with the SEC, Srivastava has control over a total of 1,725,499 common shares of the company, with 301,384 shares held directly and 1,424,115 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1580345/000159498625000034/xslF345X05/wk-form4_1765554080.xml

Price: 6.66, Change: +0.04, Percent Change: +0.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Honda Motor Plans to Launch 6 Ye Series Electric Vehicles in China by 2027
Honda Motor Plans to Launch 6 Ye Series Electric Vehicles in China by 2027
Apr 16, 2024
08:41 AM EDT, 04/16/2024 (MT Newswires) -- Honda Motor ( HMC ) said it intends to launch a total of six Ye series electric vehicle models in China by 2027, including three models that were unveiled Tuesday. The new Ye Series models introduced Tuesday - P7, S7 and GT Concept models - will be exhibited at an event to be...
Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct
Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct
Apr 16, 2024
08:42 AM EDT, 04/16/2024 (MT Newswires) -- Monopar Therapeutics ( MNPR ) said Tuesday it has filed a provisional patent application with the US Patent and Trademark Office for certain advancements in its MNPR-101 radiopharmaceutical program. The provisional patent would protect Monopar's proprietary antibody, a MNPR-101-Zr construct, which could be used for treating advanced cancers, the company said. ...
Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants
Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants
Apr 16, 2024
08:43 AM EDT, 04/16/2024 (MT Newswires) -- Inovio Pharmaceuticals ( INO ) shares slid 24% in premarket activity Tuesday after the company said late Monday that it priced its underwritten offering of common stock and pre-funded warrants, for gross proceeds of about $36 million. The offering of about 2.5 million common shares at $7.693 per share and pre-funded warrants to...
BRIEF-Rubrik Inc Sees IPO Of Up To 23 Million Shares Of Class A Common Stock- SEC Filing
BRIEF-Rubrik Inc Sees IPO Of Up To 23 Million Shares Of Class A Common Stock- SEC Filing
Apr 16, 2024
April 16 (Reuters) - Microsoft Corp ( MSFT ): * RUBRIK INC: SEES IPO OF UP TO 23 MILLION SHARES OF CLASS A COMMON STOCK- SEC FILING * RUBRIK, INC SAYS CURRENTLY ESTIMATED IPO PRICE PER SHARE WILL BE BETWEEN $28.00 AND $31.00.- SEC FILING * RUBRIK INC-OUTSTANDING SHARES OF CLASS B COMMON STOCK WILL REPRESENT ABOUT 99.3% OF VOTING...
Copyright 2023-2026 - www.financetom.com All Rights Reserved